Numerous genome-wide association studies have highlighted CD33 as a genetic risk factor for Alzheimer’s disease,5,6 although some studies report conflicting findings,7,8 indicating potential moderating factors influencing CD33’s role. The gene discussed is CD33; the disease is early-onset autosomal dominant Alzheimer disease.